Inactive Instrument
Achillion Pharmaceuticals, Inc. Stock
Stocks
US00448Q2012
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
| Treasurer | 54 | 28/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 28/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/28/20 A | Issuer sale | Chief Operating Officer | 600,000 | 0.4283% | ||
| 1/28/20 A | Issuer sale | Chief Financial Officer | 700,000 | 0.4997% | ||
| 1/28/20 A | Issuer sale | Chairman | 308,431 | 0.2202% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +9.21% | - | - | 947M | ||
| -2.69% | -0.48% | +53.97% | +66.82% | 66.33B | ||
| +0.23% | +3.09% | +11.08% | +95.60% | 60.62B | ||
| +0.98% | +1.97% | +24.66% | +90.32% | 55.5B | ||
| +0.14% | +2.35% | +13.86% | +111.94% | 47.58B | ||
| -2.21% | -2.47% | +20.18% | +28.81% | 43.69B | ||
| -2.30% | -10.40% | +154.30% | +707.36% | 37.27B | ||
| +2.15% | +1.42% | +14.58% | +48.71% | 36.57B | ||
| +2.87% | -3.28% | +79.25% | +61.25% | 32.22B | ||
| +2.62% | +5.90% | -37.29% | +386.59% | 26.58B | ||
| Average | +0.18% | +0.05% | +37.18% | +177.49% | 45B | |
| Weighted average by Cap. | -0.11% | +0.20% | +36.93% | +153.10% |
Employees
-
















